West Pharmaceutical topped Q1 estimates and raised 2025 guidance, citing stronger device demand and improved inventory trends across key markets.
Latest Ratings for WST
DateFirmActionFromTo Jul 2021KeybancMaintainsOverweight Nov 2020KeybancInitiates Coverage OnOverweight Oct 2020Stephens & Co.Initiates Coverage OnEqual-Weight